Teruki Yoshida

Shizuoka General Hospital

Papers

1

Total Citations

2

H-Index

1

About

Dr. Teruki Yoshida is a clinician-researcher whose work centers on hereditary cancer syndromes, with a particular focus on Lynch syndrome—an autosomal dominant disorder caused by germline pathogenic variants in DNA mismatch repair genes that predisposes individuals to multi-organ cancers. His major contributions lie in advancing early detection strategies for endometrial cancer, a key malignancy in Lynch syndrome. In his notable 2023 case report, Dr. Yoshida demonstrated the critical value of annual transvaginal ultrasonography and endometrial biopsy in diagnosing endometrial cancer at an early, treatable stage during routine surveillance. This work underscores the life-saving potential of rigorous screening protocols for at-risk patients. While his research portfolio is growing, with 2 citations to date, his findings have immediate clinical relevance, offering clear guidance for oncologists and genetic counselors managing Lynch syndrome families. Dr. Yoshida’s dedication to improving surveillance outcomes positions him as an emerging voice in hereditary cancer prevention, bridging the gap between genetic risk assessment and practical, patient-centered care.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Endometrial Cancer Diagnosed at an Early Stage during Lynch Syndrome Surveillance: A Case Report
2 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: Shizuoka General Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago